BioSpectra Inc. is a privately-owned manufacturer of pharmaceutical ingredients and cGMP fine chemicals. The company has been in operation for over thirty years and serves the pharmaceutical manufacturing, biopharmaceuticals, and fine chemicals sectors.
The company's core technical domains include cGMP manufacturing, pharmaceutical ingredient synthesis, fine chemical production, and biological buffer manufacturing. Its product portfolio includes bulk cGMP biological buffers, cGMP buffer solutions, cGMP process fine-chemicals, and new chemical entities (NCEs) produced to IPEC and ICH Q7 regulatory compliance levels.
BioSpectra operates seven facilities across Pennsylvania, with locations in Bangor, Stroudsburg, and Wind Gap, as well as an additional facility in Scarborough, Canada. The company has stated a commitment to sustainability, including carbon reduction efforts through the EcoVadis platform that encompass environmental and human rights considerations.
